USFDA Approves Merck's First Oral PCSK9 Inhibitor Lipfendra for High LDL Cholesterol Written By sheeba farhat17 July 2026 4:10 PM ISTBengaluru: The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs ‌dominated by injections,...
USFDA Approves First Wearable Cancer Drug Delivery System for Sanofi's Sarclisa Written By sheeba farhat13 July 2026 9:54 PM ISTLondon: The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering...
Sanofi Offers EU Antitrust Concessions in Flu Vaccine Competition Probe Written By sheeba farhat12 July 2026 10:15 AM ISTBrussels: French pharmaceutical company Sanofi has offered to state publicly that a rival flu vaccine is as effective as its own, EU antitrust...
Sanofi's Wearable Sarclisa Receives USFDA Approval for Blood Cancer Treatment Written By sheeba farhat11 July 2026 6:26 PM ISTLondon: The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering...
Novo Nordisk Brings Once-Weekly Insulin Awiqli to India Written By sheeba farhat9 July 2026 11:43 PM ISTNew Delhi: Danish drugmaker Novo Nordisk, launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete with daily-dose...
AbbVie Acquires Apogee Therapeutics for USD 10.9 Billion to Boost Immunology Pipeline Written By sheeba farhat23 Jun 2026 11:24 PM ISTBengaluru: AbbVie said on Monday it would buy biotech Apogee Therapeutics for USD 10.9 billion, in its largest buyout in more than five years as it...
FDA Advisory Panel Backs Moderna's mRNA Flu Vaccine for Adults Aged 50 and Older Written By sheeba farhat21 Jun 2026 10:15 AM ISTBengaluru: Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying...
USFDA Expands Sanofi's Tzield Use to Newly Diagnosed Type 1 Diabetes Patients Aged 8-17 Written By sheeba farhat13 Jun 2026 10:45 AM ISTBengaluru: The U.S. Food and Drug Administration said on Friday it has approved the expanded use of Sanofi's type 1 diabetes injection in children...
Mankind Pharma Appoints Nilesh Kulkarni as Group HR Head in Leadership Reshuffle Written By Parthika Patel12 Jun 2026 11:43 PM ISTNew Delhi: Mankind Pharma has appointed Nilesh Kulkarni as the Head of Human Resource Functions for the Mankind Pharma Group as part of a strategic...
Sanofi's Rare Lung Disease Drug Outperforms Standard Therapy in Head-to-Head Trial Written By sheeba farhat19 May 2026 9:58 PM ISTLondon: French drugmaker Sanofi said on Monday a trial showed its rare disease therapy was better than standard care in raising levels of a ‌key...
Sanofi Pulls Diabetes Drug Tzield from USFDA Fast-Track Review Amid Safety Concerns: Report Written By sheeba farhat7 May 2026 10:53 PM ISTBengaluru: Sanofi has asked the U.S. Food and Drug Administration to ​pull its diabetes drug ​out of the regulator's new fast-track review program,...
FDA Expands Teplizumab Approval to Infants for Delaying Type 1 Diabetes Written By Dr. Kamal Kant Kohli28 April 2026 9:00 AM ISTThe U.S. Food and Drug Administration has broadened approval of Teplizumab-developed by Sanofi-to include children as young as 1 year old, enabling...
